Inovio Pharmaceuticals (INO) vs Vivani Medical (VANI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Vivani Medical (VANI) has outperformed Inovio Pharmaceuticals (INO) over the past year, losing 10.9% versus a loss of 57.4%. Over five years, VANI leads with a -86.0% price change compared with -98.7% for INO. Inovio Pharmaceuticals is the larger company by market cap ($112.7 million vs $110.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INO | VANI |
|---|---|---|
| Share price | $1.09 | $1.23 |
| Market cap | $112.70M | $110.50M |
| 1-day change | 0.00% | -0.41% |
| YTD return | -37.36% | 0.00% |
| 1-year return | -57.42% | -10.87% |
| 5-year return | -98.71% | -85.96% |
| EPS (TTM) | $-0.90 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.72 | $1.92 |
| 52-week low | $0.56 | $0.923 |
| Distance from 52-week high | -59.93% | -36.20% |
| Analyst consensus | none | none |
| Avg. price target upside | +190.83% | +212.65% |
| Average volume | 3.86M | 228.48K |
| Shares outstanding | 103.40M | 90.20M |
| Employees | 112 | 42 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VANI has outperformed INO by 46.6 percentage points over the past year.
About Inovio Pharmaceuticals
INO stock →Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids.
Health Care · Biotechnology: Pharmaceutical Preparations · 112 employees
About Vivani Medical
VANI stock →Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 42 employees
INO vs VANI FAQ
Which is bigger, Inovio Pharmaceuticals or Vivani Medical?
Inovio Pharmaceuticals (INO) is larger, with a market capitalization of $112.70M compared with $110.50M for Vivani Medical (VANI).
Which stock has performed better over the past year, INO or VANI?
VANI returned -10.87% over the past 12 months, compared with -57.42% for INO (price return, excluding dividends). Past performance does not predict future results.
Are Inovio Pharmaceuticals and Vivani Medical in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Inovio Pharmaceuticals and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Vivani Medical.